Anti-B7H3/CD276(Vobramitamab Biosimilar) Antibody

Details and Advantages

Code: 400-045-001

Specification:

Applications: ELISA,Flow Cyt

Reactivity: Human B7H3/CD276

Conjugate: Unconjugated

Advantages:

High lot-to-lot consistency Increased sensitivity and higher affinity Animal-free production

Product Description Manual MSDS FAQ Citations

Product Detail

Description:
Anti-B7H3/CD276(Vobramitamab Biosimilar) Antibody is a biosimilar antibody directed against Human B7H3/CD276.

Isotype: Human IgG1
Conjugate: Unconjugated
Specificity: Human B7H3/CD276
Clonality: Monoclonal
Purity: Recombinant Expression and Affinity purified
Concentration: 1mg/ml
Formation: Liquid, 10mM PBS (pH 7.5)
Storage: Store at –20 °C, (Avoid freeze/thaw cycles)

FAQ

Citations

Related Products

Anti-4-1BB/CD137(Utomilumab Biosimilar) Antibody

Anti-MS4A1/CD20(Divozilimab Biosimilar) Antibody

Anti-DLL3(Rovalpituzumab Biosimilar) Antibody

Anti-PCSK9(Evolocumab Biosimilar) Antibody

Anti-OSMR(Vixarelimab Biosimilar) Antibody

Anti-IL13(Cendakimab Biosimilar) Antibody

Anti-TNF/TNFA(Placulumab Biosimilar) Antibody

Anti-VEGFA(Ranibizumab Biosimilar) Antibody